| 1 |
33002553 | Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease. | 2020 Dec |
1 |
| 2 |
31462933 | 30-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study. | 2019 |
1 |
| 3 |
27048342 | Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2016 |
2 |
| 4 |
27881129 | Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis. | 2016 Nov 23 |
3 |
| 5 |
25802727 | Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study. | 2015 Mar |
1 |
| 6 |
24824633 | Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes. | 2014 Dec |
2 |
| 7 |
24137964 | [A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition]. | 2013 |
1 |
| 8 |
20560108 | Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients. | 2010 Aug |
1 |